By David Hanson MP / Latest News / / 0 Comments

Group B Strep

This week I was a guest at Group B Strep Support’s parliamentary event on 3 July to raise awareness of group B Strep infection in newborn babies. The event marks the start of July’s Group B Strep Awareness Month.

Group B Strep is the most common cause of serious infection in newborn babies in the UK, and one of the leading causes of neonatal sepsis and meningitis. On average, two babies each day in the UK develop a group B Strep infection and each week, one baby dies from a group B Strep infection and another is left with a life changing disability.

Educating women and their families about group B Strep is crucial as it affects one in four pregnant women. Whilst I am pleased that there is a new NIHR-funded clinical trial investigating group B Strep testing, it will be reporting in 2022. In the meantime, it’s important to raise awareness of group B Strep.

During Group B Strep Awareness month, the charity is encouraging people to raise funds and raise awareness of group B Strep. A free Group B Strep Awareness Pack is available from the charity for those who wish to raise awareness in their community or workplace. It provides key facts about group B Strep in pregnancy and in young babies, including posters and leaflets.

Most group B Strep infections in newborn babies can be prevented by testing the mother late in pregnancy and providing intravenous antibiotics during labour to those who test positive. This reduces the risk of a baby developing a group B Strep infection by up to 90 per cent. The test would cost the NHS just £11 and costs from £35 privately. Pregnant women can take a simple, safe test between 35 and 37 weeks.

The UK does not routinely test pregnant women for group B Strep, unlike the United States, Canada, Germany, France, Spain and many other developed countries where all mothers-to-be are tested. The bacteria may be passed unknowingly from a mother to her baby around birth.

In the UK, there has been a rise of almost a third (31%) in the rate of group B Strep infections in babies under three months of age since 2000, despite risk-based prevention guidelines being introduced in 2003. By contrast, in countries that routinely test pregnant women for group B Strep carriage, the incidence has fallen dramatically, by up to 86%. The rate in the United States of early-onset GBS infections (those in the first six days of life) is now less than half that of the UK.

Jane Plumb MBE, Chief Executive and founder of Group B Strep Support charity, said: “The current UK policy on group B Strep is not working. At present, pregnant women are assessed for risk factors or group B Strep developing in the baby. However, we’re missing lots of babies whose mums don’t have risk factors but do carry the bacteria. This means we’re putting newborns at a terrible risk of dying or suffering from devastating long-term health condition. This situation cannot continue.”

Since late 2017 the Royal College of Obstetricians and Gynaecologists guideline on group B Strep has recommended that all pregnant women should be provided with a leaflet on group B Strep during pregnancy. (This leaflet can be downloaded from the charities website).